Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Report Code: HLC078A

Publish Date: Aug 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • In the U.S., recent reimbursement changes and the economic downturn have called the expanding use of MRI scanning into question. The North American market is worth $2.3 billion in 2010 and is expected to increase at a 4.4% compound annual growth rate (CAGR) to reach $2.9 billion in 2015.
  • Europe ranks with the U.S. as one of the most developed MRI markets. Expanding applications in the neurologic, cardiac, and breast MRI areas should drive the EU market. This sector is estimated at $1.2 billion in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $1.9 billion in 2015.
  • Japan remains an early adopter of newer MRI equipment, making it a prime opportunity for newer 3T equipment. This market is valued at $1 billion in 2010 and should reach $1.3 billion in 2015, a compound annual growth rate (CAGR) of 4.3%.

INTRODUCTION

REASONS FOR DOING THE STUDY
 
Medical imaging costs make up one of the fastest-growing components of overall healthcare costs, and medical resonance imaging (MRI) is one of the leading imaging technologies used by healthcare providers. Whether the imaging is done for diagnostic or interventional reasons, the market for MRI is expanding.
 
Medical imaging through the use of MRI equipment accounts for approximately 25% of the medical imaging technologies used globally. Determining the influence of MR imaging on future healthcare trends and the viability for market expansion in a stringent reimbursement and regulatory environment are key reasons for conducting this market study. 
 
Macro trends that benefit the MRI market include: an aging worldwide population; continued global urbanization; prevalence of major diseases such as heart disease, cancer, and diabetes; and expanding access to healthcare products and services, particularly in rural areas and for younger populations. Negative global trends include stricter medical insurance reimbursement policies and economic turbulence throughout the world.
 
The study will explore the keys to continued growth in this industry, including increasing sales in developing regions, expanded services, a strong pipeline of new products, and new applications for existing technologies. 
 
STUDY GOALS AND OBJECTIVES
 
The goal of this study is to describe and discuss changes in the global MRI market. Thisreport is designed to achieve the following objectives:
  • To describe the trends and developments for each type of MRI technology and how each is meant to satisfy the needs of manufacturers.  
  • To analyze market and driving forces to determine the market size for the technologies and pinpoint target applications.  
  • To examine the MRI business in terms of specific companies and their position in the market.
The report is designed to appeal to many different readers including venture capitalists interested in exploring commercialization opportunities, marketing and management individuals within the industry, and even the casual reader who desires to understand how market pressures and technology interact in this industry.   
 
SCOPE OF REPORT 
 
This technical market report organizes information from diverse sources into a cohesive unit that includes overview, industry structure, and technology sections. 
 
The report examines the MRI equipment industry in general, the types of technology currently in use as well as future applications, and regulatory influences. The industry structure section discusses the most active suppliers with regard to relative market share, marketing strengths, and forces that promote or hamper growth of technologies. The technology sections detail historical, current, and projected (2010 through 2015) market values.    
 
METHODOLOGIES AND INFORMATION SOURCES
 
The data for this report was gathered from primary and secondary sources. Primary data was obtained from industry personnel and government agencies. Secondary sources include information gleaned from trade journals; the U.S. Patent and Trademark Office (USPTO); company reports; press releases; product literature; and government documents. Where precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data. 
 
ANALYST CREDENTIALS
 
Peggy S. Lehr is the BCC Research Analyst of this report. Ms. Lehr has worked within the publishing arms of for-profit and not-for-profit organizations, and she specializes in marketing reports on the medical industry. She has authored several market research reports for BCC Research. 

BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use. 
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets135Free
Chapter- 1: INTRODUCTION 3Free
Chapter- 2: SUMMARY 3Free
Chapter- 3: OVERVIEW20Free
Chapter- 4: MRI EQUIPMENT OVERVIEW11Free
Chapter- 5: THE GLOBAL MARKET FOR MRI EQUIPMENT 8Free
Chapter- 6: CURRENT MRI APPLICATIONS 15Free
Chapter- 7: REGULATIONS AND REIMBURSEMENT 10Free
Chapter- 8: PATENTS 14Free
Chapter- 9: EMERGING TECHNOLOGY AND APPLICATIONS4Free
Chapter- 10: COMPANY DIRECTORY34Free
Chapter- 11: GLOSSARY13Free

Related Reports

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
Customize Report